Results 10,201-10,220 of 34,729 for speaker:Seán Fleming
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: We would not know the names.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: When Ms Carr refers to causation, does that mean that a person has to prove that his or her mother took thalidomide? For the people watching this, what does "causation" mean?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: By "causation", Ms Carr means that it has to be proven that the person has a disability and his or her mother took thalidomide. Ms Carr is saying some people could have a disability and their mothers might not have taken thalidomide but it is presumed they did.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: They found out their mothers did not take thalidomide and the disability is unconnected to the drug. I am trying to get this into layman's English. From visual appearance, two people can appear to have been affected by thalidomide but Ms Carr is saying that may not be the case.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: There are different defects.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: This is an old issue that surfaces every so often. That is why we are having discussing the matter at a simple level. People come to us and state they have been affected by thalidomide but they got nothing. Perhaps we can explain this a bit better now.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: I thank Ms Carr.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: We will move on from the next main item in the note, the chapter on 2012 which is now six years old and is just a bit of history.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: I will make one small point we touched on earlier. The HSE has a steering group, which was mentioned, and an implementation group. Mr. McCallion stated one third of the recommendations fall outside the scope of the HSE and within the scope of, for example, the Department. Who is overseeing the implementation of these recommendations where they impinge on the Department rather than the HSE?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: In other words, it is a steering committee-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: -----that is specifically dealing with the recommendations relating to the Department of Health whereas the HSE has its own implementation committee.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is it a so-called subsidiary?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Dr. Scally is helping in that regard. When will the HSE have the implementation plan?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is it weeks away?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is it only after Dr. Scally has given the plan the okay or made his observations that we will see the implementation plan?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: In other words, Dr. Scally will give it his imprimatur or otherwise.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: These will be issues that he wants added.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Will that be done before Christmas?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: The only observation I will make is that the committee is regularly told recommendations have been made and there is an implementation plan. In the case of other organisations, we have found 12 months later that 70% of the recommendations have been implemented and several have not been implemented. The issue is the follow through. The HSE has accepted the report. This morning, members...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: I put him on notice that in six months or when the time comes he will be before us to explain implementation.